Selective laser trabeculoplasty (SLT) and retinal photocoagulation (RP) are two common laser procedures frequently performed using a 532 nm (green light) laser.
SLT is a commonly performed therapeutic procedure for the treatment of open-angle glaucoma. It can be used either as a primary therapy or as an adjunctive therapy. Further, it has the advantage of not being reliant on patient compliance with eye drops, which has been reported to be low.1 Compared with its predecessor, argon laser trabeculoplasty, SLT results in a lack of visible trabecular meshwork scarring and fewer side effects, while still resulting in a decrease in intraocular pressure comparable to argon laser trabeculoplasty in both newly diagnosed patients and patients with maximally tolerated medication.2 Adverse effects as a result of SLT, such as corneal edema, are relatively uncommon and usually transient.3
RP is used in retinal ischemia, such as diabetic retinopathy and retinal vein occlusion, where the conversion of laser energy to thermal energy destroys ischemic peripheral retina, reducing the metabolic demands of the tissue and vascular endothelial growth factor production, and thus decreasing neovascularization.4,5 RP can also be used to treat retinal holes and tears where slight inflammation and scarring cause choroid adhesion to the retina.6 Adverse effects from RP include declines in visual acuity and visual field.7
In both SLT and RP, the corneal endothelium may be affected. In SLT, to reach the trabecular meshwork, laser energy must traverse the cornea, and in RP the laser energy passes through the cornea to reach the retina. The corneal endothelium consists of a single layer of nonregenerating, hexagonal cells that function to maintain corneal transparency by regulating the hydration of the cornea.8 When the corneal endothelium is damaged, the normally small and regular hexagonal cells enlarge to cover the inner surface of the cornea and compensate for the loss of cells.9 Corneal endothelial cell density decreases with age, and also after trauma to the cornea.9
Previous research has found the presence of transient “dark spots on corneal specular microscopy” that appear immediately post-SLT and seem to resolve by 1 month.10,11 Furthermore, altered immunostaining for zonula occludens-1 (ZO-1) suggests that after SLT, corneal endothelial tight junctions may be compromised.12 There have been mixed results regarding quantitative changes to corneal endothelial cell parameters, with Ong et al finding no difference to corneal cell density but a larger study by Lee et al finding a transient cell decrease at 1 week that seemed to recover by 1 month.13,14
Patients with diabetic retinopathy are known to have abnormally high levels of pleomorphism and polymegathism in the corneal endothelium.15 Argon laser retinal photocoagulation (with a wavelength 514 nm) has been found to decrease endothelial density in patients with diabetic retinopathy.16 However, it is not known whether modern RP, performed with a laser with a wavelength of 532 nm, will affect the corneal endothelium. Thus, the present study aimed to determine if there were demonstrable quantitative and morphological changes to the corneal endothelium from SLT or RP on specular microscopy.
This was a retrospective cohort study of patients and all procedures were performed by the same ophthalmologist (K.O.). From April 2017 to June 2018, 249 eyes from 136 consecutive patients who underwent SLT for open-angle glaucoma were included and 132 eyes from 74 patients who underwent RP for retinal conditions, including retinal holes, tears, or degeneration and diabetic retinopathy. Exclusion criteria included patients with concurrent corneal disease, such as Fuchs’ corneal dystrophy. Patients taking medications affecting the cornea, such as amiodarone and hydroxychloroquine, were excluded. For the SLT cohort, patients were included who had open-angle glaucoma and where SLT was offered as an adjuvant intraocular pressure-lowering therapy. The protocol (Reference Code: RESP/18/154) was approved by the Northern Sydney Local Health District Human Research Ethics Committee and the tenets of the Declaration of Helsinki were adhered to (Tables 1–3).
The Ellex Tango (Ellex Medical Pty Ltd, Adelaide, Australia) laser was used for the SLT procedure. Power settings were titrated to 0.3–0.9 mJ to achieve the reaction of a hint of microbubbles in 80% of laser shots. About 60 ± 10 laser shots to 180 degrees of meshwork were done. Total laser energy, peak laser energy, and number of laser shots were recorded. Post-SLT all treated eyes were given a single drop of Maxidex, containing dexamethasone 0.1% (Alcon Inc, Fort Worth, Texas, USA), one drop of Acular, containing ketorolac tromethamine 0.5% (Allergan Inc, Irvine, California, USA), and one drop of Combigan containing combined timolol maleate 0.5% and brimonidine tartrate 0.2% (Allergan Inc, Irvine, California, USA). If patients were asthmatic, instead of Combigan, they were given one drop of Alphagan containing only brimonidine tartrate 0.2% (Allergan Inc, Irvine, California, USA).
The Ellex Solitaire (Ellex Medical Pty Ltd, Adelaide, Australia) laser was used for the RP procedure. The spot size was 300 μm and pulse duration 0.1 s, with power titrated to 200–400 mW and 150–500 shots given to achieve a light to medium white-grey burn.
Corneal specular microscopy was performed using the Tomey EM-3000 Corneal Specular Microscope (Tomey Corporation, Nagoya, Japan). The microscope was set to examine the central cornea, identified using the patient's fixation. Specular microscopy was performed immediately before and after each procedure (approximately 20 minutes postprocedure), and at 1-month postprocedure. Up to three images were taken, and image analysis was automated using the inbuilt software. All images were taken by the same ophthalmologist (K.O.). Images were not included for analysis if they included less than 75 cells in the image. This cut point was determined by balancing the fact that there is increased reliability from an image including more cells (ie, higher image quality) with the present study's cohort having a high average age and thus lower corneal endothelial cell density.9,17
Specular microscopy analysis was carried out as established by McCarey et al.9 Parameters examined included corneal endothelial cell count, coefficient of variance of cell area, percentage of hexagonal cells, and central corneal thickness (CCT). All parameters are collated automatically by the microscope's inbuilt software. The coefficient of variance of cell area is a measure that quantifies polymegathism. It is calculated by dividing the standard deviation of the mean cell area by the value of mean cell area. Thus, a larger value implies a greater amount of cell size variability. The percentage of hexagonal cells is a measure quantifying pleomorphism. Although the normal corneal endothelium in young subjects has approximately 60% of its cells as hexagonal, stress to the corneal endothelium reduces the percentage of hexagonal cells.9
A repeated measures analysis of variance with nested design was used to test for differences at each time point for corneal endothelial cell density, CCT, coefficient of variance in cell size, and percentage of hexagonal cells. This design accounts for the lack of complete independence using both eyes from some patients.18 The association of peak laser energy, total laser energy, and total laser shots with the aforementioned parameters was performed using Pearson correlations.
There were 244 eyes from 133 patients who underwent SLT for open-angle glaucoma. Of these patients, 61 (45.8%) were men, and the mean age was 70.4 ± 11.4. A majority of the patients, 105 (78.9%), were of Asian ethnicity. Of the eyes included in the analysis, 123 (50.4%) were left eyes and 121 (49.6%) were right eyes. In the SLT cohort, the mean number of glaucoma eye drops used was 1.4 ± 0.9. The mean CCT was 536 ± 38 μm. For the SLT procedures, the mean number of laser shots was 61.1 ± 13.3 shots, the mean peak energy was 0.87 ± 0.24 mJ, and the mean total laser energy was 40.6 ± 17.4 mJ.
In the RP cohort, there were 132 eyes from 74 patients. The vast majority of patients (n = 72) received RP to treat retinal holes, tears, and degeneration, with the remaining 2 patients treated with RP for diabetic retinopathy. In the RP cohort, 36 (48.6%) were men, and the mean age was 64.7 ± 14.2. A majority of the patients, 61 (82.4%), were of Asian ethnicity. Of the eyes included in the analysis, 64 (48.5%) were left eyes and 68 (51.5%) were right eyes. The mean CCT was 541 ± 36 μm. Data regarding treatment parameters of the photocoagulation procedure was not collected as the information would not be useful due to the different retinal conditions treated.
The mean endothelial cell density pre-RP was 2292 ± 449 cells/mm2, which decreased to 2265 ± 445 cells/mm2 and increased slightly to 2279 ± 448 cells/mm2 at 1 month. There was a statistically significant decrease between baseline and post-SLT (P = 0.008) and a statistically significant increase between post-SLT and 1 month (P = 0.04). Overall there was a statistically significant decrease between pre-SLT and at 1 month (P = 0.04).
The mean coefficient of variance of cell area was 38.5 ± 6.0 pre-SLT, 38.2 ± 6.9 post-SLT, and 38.8 ± 6.6 at 1 month. There were no significant differences between the means at any time points.
The proportion of hexagonal cells was 50.3 ± 8.2% pre-SLT, 49.3 ± 9.2% post-SLT, and 51.2 ± 8.6% at 1 month. There was no significant difference between pre-SLT and post-SLT (P = 0.15), but there was a significant increase between post-SLT and 1 month (P = 0.03).
The mean CCT was 536 ± 38 μm pre-SLT, and this increased to 539 ± 41 μm post-SLT and decreased to 537 ± 41 μm at 1 month. The increase between baseline and post-SLT was statistically significant (P = 0.03), however, there was no significant difference between baseline and 1 month (P = 0.6).
Total laser energy was not correlated with the change to the CCT immediately post-SLT (P > 0.2) but was correlated with CCT increase at 1 month (r = 0.26, P = 0.01). No other correlations between either total laser energy or peak laser energy and any quantitative or morphological parameters were significant.
Retinal Photocoagulation Cohort
The mean endothelial cell density pre-SLT was 2559 ± 308 cells/mm2, which was unchanged at 2549 ± 287 cells/mm2 post-RP and 2549 ± 307 cells/mm2 at 1 month.
The mean coefficient of variance of cell area was 38.1 ± 5.5 pre-RP, 40.2 ± 6.8 post-RP, and 39.4 ± 6.4 at 1 month. There was a significant increase (P = 0.001) between pre-RP and post-RP but no change between post-RP and 1 month.
The proportion of hexagonal cells was 50.6 ± 8.0% pre-RP, 50.1 ± 7.3% post-RP, and 50.4 ± 8.2% at 1 month. There were no significant changes between any time points.
The mean CCT was 541 ± 34 μm pre-RP and was 543 ± 35 μm post-RP and 543 ± 35 μm at 1 month. There were no significant changes between any time points.
No patients in this cohort developed complications attributable to the RP procedure.
The present study found quantitative and morphological changes to the corneal endothelium after SLT that seem to begin recovering by 1 month. There was a small (just over 1%) but statistically significant reduction in corneal endothelial cell count from pre-SLT to post-SLT, and a statistically significant recovery at 1 month. Although polymegathism, as measured by the coefficient of variance in cell area, did not change, changes in pleomorphism were observed. The proportion of hexagonal cells did not change between pre-SLT and post-SLT, but there was a statistically significant 2% increase between post-SLT and 1 month. The only change of note in the RP group was an increase in polymegathism between pre-RP and post-RP.
SLT and RP are laser procedures commonly performed at a wavelength of 532 nm. In this study, mean laser energy for SLT was 40.6 ± 17.4 mJ, and although RP laser energy was not recorded individually, with settings of 200–400 mW and 300 μm spot size over 0.1 s duration, total energy delivered would be 15–30 mJ.11 SLT uses a short 3 ns pulse, whereas RP uses a longer 0.1 s pulse. Thus, although both procedures use similar amounts of laser energy, it is possible that the delivery of this energy over a much shorter time period contributes to the greater degree of changes to the corneal endothelium after SLT observed here.
To the best of the authors’ knowledge, this is the first cohort study looking at changes to the corneal endothelium after RP. Previously, argon laser photocoagulation (with a wavelength of 514 nm) had been found to decrease endothelial cell density, whereas in a contemporary cohort RP performed before vitrectomy protected against endothelial cell damage.16,19 Although RP did not change endothelial cell density, it seemed to transiently increase polymegathism, suggesting that there may still be stress on the corneal endothelium. Longer term studies are needed to confirm this. It should also be noted that the RP cohort here had a higher baseline endothelial cell density, probably due in part to the younger average age. There were also very few RP procedures performed for diabetic retinopathy in this cohort, and thus further research is required in this group.
Quantitative changes to corneal endothelial cell density after SLT were similar to previous studies. Lee et al found a 5% decrease in cell count at 1 week that recovered (though not entirely to baseline levels) by 1 month.14 The higher drop in cell count may be explained by the higher energy used in their SLT procedure, with mean total laser energy of 163 mJ compared with 40.6 mJ in the present study. Ong et al, in a previous study, found no significant change in cell count after SLT, though it is likely that study was underpowered to detect this relatively subtle change.13
Few morphological changes were observed, with no change from pre-SLT to post-SLT and only a slight increase in hexagonal cells from post-SLT to 1 month. The percentage of hexagonal cells is a measure of pleomorphism, and a healthy cornea will have approximately 60% of hexagonal cells.9 A reduction in this value may indicate stress to endothelial cells. The present study may have been underpowered to detect a decrease between pre-SLT and post-SLT, though the increase by 1 month suggests an ongoing remodeling process. Although changes in polymegathism, represented by the coefficient of variance of cell area, were not noted here, polymegathism has been shown to increase in patients undergoing SLT for pseudoexfoliative glaucoma.20
CCT was transiently increased between pre-SLT and post-SLT. This is in contrast with the study by Lee et al, which found a transient decrease in CCT, whereas a cohort study by Guven Yilmaz et al found an increase in CCT persisting to 1 month post-SLT.21 On one hand, SLT may cause endothelial cell dysfunction, leading to corneal edema and an increase in CCT. On the other hand, SLT may induce stromal contractions caused by the dissipation of heat energy from the laser, decreasing CCT.14 It remains unclear which of these mechanisms is dominant, and may be influenced by other factors, such as Lee et al’ use of topical nonsteroidal anti-inflammatory drugs for 1 day post-SLT.14 Regardless, the present study concurs with Lee et al in the return to CCT baseline at 1 month, this may be due to stromal remodeling and corneal healing.22
Although clinically significant complications after SLT are rare, changes to the corneal endothelium have been documented. White et al noted dysmorphic cells and increased intracellular spacing on confocal microscopy after SLT.23 They suggested this might be the result of endothelial cell swelling.
The mechanism for these changes is still not well understood. Leahy et al found decreased and irregular ZO-1 staining in cadaver eyes undergoing SLT, suggesting that endothelial tight junctions may be dysfunctional.12 A previous study on rabbit eyes treated with SLT showed an increase in oxygen-free radicals in the aqueous humour after the procedure, and this may mediate this damage to the tight junctions.24
One limitation in the present study was that ideally the examiner of the specular microscopy image should have been blinded to whether the image was pre- or postprocedure. This was not done due to resource limitations, but may have introduced some measurement bias.
In conclusion, SLT causes a transient decrease in endothelial cell density and an increase in CCT, and there may be changes to pleomorphism, though this was only significant for the recovery between post-SLT and 1 month. RP seems to have significantly less impact on the corneal endothelium, with the only change of note an increase in polymegathism between pre-RP and post-RP. Overall the changes observed in the present study are minor and unlikely to be of clinical significance.
1. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol
2008; 53: (suppl 1): S57–S68.
2. Wong MO, Lee JW, Choy BN, et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol
3. Moubayed SP, Hamid M, Choremis J, et al. An unusual finding of corneal edema complicating selective laser trabeculoplasty. Can J Ophthalmol
4. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA
5. Neubauer AS, Ulbig MW. Laser treatment in diabetic retinopathy. Ophthalmologica
6. Yoon YH, Marmor MF. Rapid enhancement of retinal adhesion by laser photocoagulation. Ophthalmology
7. Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina
8. Janson BJ, Alward WL, Kwon YH, et al. Glaucoma-associated corneal endothelial cell damage: a review. Surv Ophthalmol
9. McCarey BE, Edelhauser HF, Lynn MJ. Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea
10. Ong K. SLT may compromise the corneal endothelium. Asian J Ophthalmol
11. Ong K, Ong L, Ong L. Corneal endothelial changes after selective laser trabeculoplasty. Clin Exp Ophthalmol
12. Leahy KE, Madigan MC, Sarris M, et al. Investigation of corneal endothelial changes post selective laser trabeculoplasty. Clin Exp Ophthalmol
13. Ong K, Ong L, Ong LB. Corneal endothelial abnormalities after selective laser trabeculoplasty (SLT). J Glaucoma
14. Lee JW, Chan JC, Chang RT, et al. Corneal changes after a single session of selective laser trabeculoplasty for open-angle glaucoma. Eye (Lond)
15. Schultz RO, Matsuda M, Yee RW, et al. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol
16. Pardos GJ, Krachmer JH. Photocoagulation: its effect on the corneal endothelial cell density of diabetics. Arch Ophthalmol
17. Binder PS, Akers P, Zavala EY. Endothelial cell density determined by specular microscopy and scanning electron microscopy. Ophthalmology
18. Armstrong RA, Eperjesi F, Gilmartin B. The application of analysis of variance (ANOVA) to different experimental designs in optometry. Ophthalmic Physiol Opt
19. Zhong J, Jia J, Yu J, et al. Preoperative photocoagulation reduces corneal endothelial cell damage after vitrectomy in patients with proliferative diabetic retinopathy. Medicine (Baltimore)
20. Ornek N, Ornek K. Corneal endothelial changes following a single session of selective laser trabeculoplasty for pseudoexfoliative glaucoma. Int Ophthalmol
21. Guven Yilmaz S, Palamar M, Yusifov E, et al. Effects of primary selective laser trabeculoplasty on anterior segment parameters. Int J Ophthalmol
22. Shih CY, Graff Zivin JS, Trokel SL, et al. Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol
23. White AJ, Mukherjee A, Hanspal I, et al. Acute transient corneal endothelial changes following selective laser trabeculoplasty. Clin Exp Ophthalmol
24. Guzey M, Vural H, Satici A, et al. Increase of free oxygen radicals in aqueous humour induced by selective Nd:YAG laser trabeculoplasty in the rabbit. Eur J Ophthalmol